drugset / Trial / NCT02308228

Metformin to Augment Strength Training Effective Response in Seniors (MASTERS)

NCT02308228 ↗

RandomizedParallel-groupTriple-blindSupportive care

Summary

The purpose of this study is to determine whether a commonly prescribed drug, metformin, can enhance the benefits seen during resistance exercise such as increased muscle mass and strength.

Timeline

Start
2015-01-14
Primary completion
2017-12-14
Completion
2018-06-28

Outcome

Missed primary endpoint

paper Although responses to PRT varied, placebo gained more lean body mass (p = .003) and thigh muscle mass (p < .001) than metformin. PMID 31557380 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1700 mg —

Indications

No indication recorded.